[HTML][HTML] Emerging therapies against infections with Pseudomonas aeruginosa

B Tümmler - F1000Research, 2019 - ncbi.nlm.nih.gov
Infections with Pseudomonas aeruginosa have been marked with the highest priority for
surveillance and epidemiological research on the basis of parameters such as incidence …

Emerging therapies against infections with Pseudomonas aeruginosa.

B Tümmler - F1000research, 2019 - europepmc.org
Infections with Pseudomonas aeruginosa have been marked with the highest priority for
surveillance and epidemiological research on the basis of parameters such as incidence …

Emerging therapies against infections with Pseudomonas aeruginosa

B Tümmler - F1000Research, 2019 - pubmed.ncbi.nlm.nih.gov
Infections with Pseudomonas aeruginosa have been marked with the highest priority for
surveillance and epidemiological research on the basis of parameters such as incidence …

Emerging therapies against infections with Pseudomonas aeruginosa

B Tümmler - F1000Research, 2019 - cir.nii.ac.jp
抄録< ns4: p> Infections with< ns4: italic> Pseudomonas aeruginosa</ns4: italic> have been
marked with the highest priority for surveillance and epidemiological research on the basis …

Emerging therapies against infections with Pseudomonas aeruginosa [version 1; peer review: 2 approved].

B Tümmler - 2019 - cabidigitallibrary.org
Infections with Pseudomonas aeruginosa have been marked with the highest priority for
surveillance and epidemiological research on the basis of parameters such as incidence …

[HTML][HTML] Emerging therapies against infections with Pseudomonas aeruginosa

B Tümmler - F1000Research, 2019 - f1000research.com
Infections with Pseudomonas aeruginosa have been marked with the highest priority for
surveillance and epidemiological research on the basis of parameters such as incidence …

[HTML][HTML] Emerging therapies against infections with Pseudomonas aeruginosa

B Tümmler - F1000Research, 2019 - f1000research.com
Infections with Pseudomonas aeruginosa have been marked with the highest priority for
surveillance and epidemiological research on the basis of parameters such as incidence …

Emerging therapies against infections with Pseudomonas aeruginosa.

B Tümmler - F1000research, 2019 - europepmc.org
Infections with Pseudomonas aeruginosa have been marked with the highest priority for
surveillance and epidemiological research on the basis of parameters such as incidence …